课题基金 / 基金详情

项目摘要

项目成果

HABIBE KARACAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Radiolabeling, Quality Assurance, and Immunoassay Core will provide a variety of services for the participants of this Program Project. This Core Facility has been providing these same services to CMMI investigators for 20 years. The primary responsibility of this core involves the preparation of radiolabeled agents for investigators. This includes the processing, receipt, preparation, quality assurance and disposal of the radiolabeled materials. This laboratory has experience in preparing radiolabeled antibodies and peptides with 1311,1251,123I, " V 90Y, 188Re, 99mTc, 212Bi, and 67Ga. Each product that is produced undergoes a series of quality assurance checks, including ITLC, size-exclusion HPLC, and Immunoreactivity determinations. All equipment used in this laboratory is calibrated regularly and all procedures are performed under SOPs. This laboratory also produces radiolabeled investigational agents for a number of INDs, and has experience in developing procedures to ensure product stability when shipped to extramural investigational sites. This core is also involved in the processing of blood and urine samples used for pharmacokinetic analysis, as well as plasma samples for anti-antibody assays. This Core will be utilized by Projects 1,2, and 4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMPROVING TUMOR RADIOIMMUNOTHERAPY BY PNA PRETARGETING
  • 批准号:
    2645330
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    1998
  • 负责人:
    HABIBE KARACAY
  • 依托单位:
海外基金